Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Pre-medication With Alfentanil vs Placebo During ECT [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examined pre-medication with Alfentanil versus placebo during electroconvulsive therapy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfentanil (alfentanil)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Blood Pressure, Electroconvulsive Therapy | Phase 4 | Status: COMPLETED | Results posted: 2021-07-08